G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Obesity and metabolic syndrome display disparate prevalence and regulation between males and females. Human, as well as rodent, females with regular menstrual/estrous cycles exhibit protection from weight gain and associated chronic diseases. These beneficial effects are predominantly attributed to the female hormone estrogen, specifically l7β-estradiol(E2). E2 exerts its actions via multiple receptors, nuclear and extranuclear estrogen receptor (ER) α and ERβ, and the G-protein-coupled estrogen receptor (GPER, previously termed GPR30). The roles of GPER in metabolic homeostasis are beginning to emerge but are complex and remain unclear. The discovery of GPER-selective pharmacological agents (agonists and antagonists) and the availability of GPER knockout mice have significantly enhanced our understanding of the functions of GPER in normal physiology and disease. GPER action manifests pleiotropic effects in metabolically active tissues such as the pancreas, adipose, liver, and skeletal muscle. Cellular and animal studies have established that GPER is involved in the regulation of body weight, feeding behavior, inflammation, as well as glucose and lipid homeostasis. GPER deficiency leads to increased adiposity, insulin resistance, and metabolic dysfunction in mice. In contrast, pharmacologic stimulation of GPER in vivo limits weight gain and improves metabolic output, revealing a promising novel therapeutic potential for the treatment of obesity and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 2×
“Postmenopausal women experience a decline in metabolic health due to increased android fat deposition, reduced energy expenditure, insulin resistance, impaired glucose/lipid metabolism, and inflammation (Mauvais-Jarvis 2011; Poehlman et al. 1995; Lobo 2008; Abu-Taha et al. 2009; Godsland 2005; Bruns and Kemnitz 2004;…”
BackgroundRetractedIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“Rodent models of obesity and patients with type 2 diabetes also exhibit increased oxidative stress and inflammation (Furukawa et al. 2004; Fernandez-Sanchez et al. 2011; Wright et al. 2006; Folli et al. 2011; Domingueti et al. 2016).”
BackgroundGuh, D. P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C. L., & Anis, A. H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-88 · Cited by 3,855 · cited 2×
“It is now recognized as a global epidemic with the number of obese individuals increasing drastically over the last two to three decades in both developed and more recently developing nations (Flegal et al. 2010; Guh et al. 2009).”
BackgroundPoirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583 · cited 2×
“Obesity leads to altered secretory profiles of adipose-specific hormones and cytokines, increased levels of circulating glucose and lipids, and systemic inflammation, resulting in ectopic lipid deposition in peripheral metabolic tissues, such as the pancreas, liver, and skeletal muscle (Shulman 2014; Klop et al. 2013;…”
BackgroundA transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Self-citationObesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806 · cited 1×
“…glucose and lipids, and systemic inflammation, resulting in ectopic lipid deposition in peripheral metabolic tissues, such as the pancreas, liver, and skeletal muscle (Shulman 2014; Klop et al. 2013; Consitt et al. 2009; Bays et al. 2013; Shoelson et al. 2007; Tchernof and Despres 2013).”
BackgroundIslet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Shulman, G. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1011035 · Cited by 1,126 · cited 4×
“Obesity leads to altered secretory profiles of adipose-specific hormones and cytokines, increased levels of circulating glucose and lipids, and systemic inflammation, resulting in ectopic lipid deposition in peripheral metabolic tissues, such as the pancreas, liver, and skeletal muscle (Shulman 2014; Klop et al. 2013;…”
BackgroundInfluential
Cited by
The regulation of adipose tissue health by estrogens
Steiner, B. M., & Berry, D. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.889923 · Cited by 171
G protein-coupled estrogen receptor in immune cells and its role in immune-related diseases
Notas, G., Kampa, M., & Castanas, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.579420 · Cited by 109
Targeting the G protein-coupled estrogen receptor (GPER) in obesity and diabetes
Sharma, G., & Prossnitz, E. R. (2021) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2021.100080 · Cited by 34
Self-citationXiang, G., Guo, S., Xing, N., Du, Q., Qin, J., Gao, H., Zhang, Y., & Wang, S. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500150 · Cited by 18
Liu, L., Zhou, Y., Liu, J., Zhang, X., He, C., Zeng, X., Dejenie, R., Zeb, U., Zeng, Q., Liu, L., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07005-0 · Cited by 13
“Interestingly, sex differences further highlight the role of GPER, with females exhibiting superior fatty acid metabolism, likely due to estrogen and its receptors [102, 103].”
Metadata
- Authors
- Sharma, G., & Prossnitz, E. R.
- Venue
- Advances in Experimental Medicine and Biology
- Publisher
- Springer International Publishing
- Published
- 2017
- Volume
- 1043
- Pages
- 427-453
- ISSN
- 0065-2598 (ISSN-L)
- 2214-8019
- OpenAlex
- W2775249880
- Cited by
- 88
- References
- 38
- FWCI
- 26.42
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis. https://app.cochat.ai/papers/10.1007/978-3-319-70178-3_20
- The paper
- Sharma, G., & Prossnitz, E. R. (2017). G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis. Advances in Experimental Medicine and Biology. https://doi.org/10.1007/978-3-319-70178-3_20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.